Comparitive distribution of resistance patterns and serotypes in Pseudomonas aeruginosa isolates from intensive care units and other wards

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 4, 1996, Pages 809-813

  Bert, F ^a   Lambert Zechovsky, N ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AZTREONAM; BACTERIAL ENZYME; CEFTAZIDIME; CEPHALOSPORINASE; CIPROFLOXACIN; FOSFOMYCIN; GLUCOSE 6 PHOSPHATE; IMIPENEM; PENICILLINASE; PIPERACILLIN; TICARCILLIN; TIMENTIN; TOBRAMYCIN; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; HOSPITAL INFECTION; INTENSIVE CARE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SEROTYPE; WARD; CLASSIFICATION; CROSS INFECTION; DRUG EFFECT; ENZYMOLOGY; HUMAN; INTENSIVE CARE UNIT; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE; PHENOTYPE; SEROTYPING;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CEPHALOSPORINASE; CEPHALOSPORINS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; HUMANS; INTENSIVE CARE UNITS; PENICILLINASE; PENICILLINS; PHENOTYPE; PSEUDOMONAS AERUGINOSA; SEROTYPING;

EID: 0029666248     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.4.809     Document Type: Article

References (10)

1. Allemeersch, D., Beumer, J., Devleeschouwer, M., De Maeyer, S., Dony, J., Godard, C. et al. (1988). Marked increase of Pseudomonas aeruginosa serotype O12 in Belgium since 1982, European Journal of Clinical Microbiology and Infectious Diseases 7, 265-9.
2. Dette, G. A., Knothe, H., Schäfer, V. & Pirlet-Berninger, U. (1988). Serotyping, sites of isolation and resistance of Pseudomonas aeruginosa. Microbiologica 11, 129-35.
3. Farmer, J. J., Weinstein, R. A., Zierdt, C. H. & Brokopp, C. D. (1982). Hospital outbreaks caused by Pseudomonas aeruginosa: importance of serogroup O11. Journal of Clinical Microbiology 16, 266-70.
4. Legakis, N. J., Aliferopoulou, M., Papavassiliou, J. & Papapetropoulou, M. (1982). Serotypes of Pseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility. Journal of Clinical Microbiology 16, 458-63.
5. Legakis, N. J., Koukoubanis, N., Malliara, K., Michalitsianos, D. & Papavassiliou, J. (1987). Importance of carbenicillin and gentamicin cross-resistant serotype O:12 Pseudomonas aeruginosa in six Athens hospitals. European Journal of Clinical Microbiology and Infectious Diseases 6, 300-3.
6. Livermore, D. M. & Pitt, T. L. (1986) Dissociation of surface properties and "intrinsic" resistance to β-lactams in Pseudomonas aeruginosa. Journal of Medical Microbiology 22, 217-24.
7. Livermore, D. M., Pitt, T. L., Jones, C. S., Crees-Morris, J. A. & Williams, R. J. (1985). PSE-4 beta-lactamase: a serotype-specific enzyme in Pseudomonas aeruginosa. Journal of Medical Microbiology 19, 45-53.
8. Philippon, A., Thabaut, A. & Nevot, P. (1985). Pseudomonas aeruginosa et beta-lactamines. In L'Antibiogramme (Courvalin, P., Goldstein, F., Philippon, A., & Sirot, J., Eds), pp. 103-10. MPC - Vidéom, Paris.
9. Pitt, T. L., Livermore, D. M., Miller, G., Vatopoulos, A. & Legakis, N. J. (1990). Resistance mechanisms of multiresistant serotype O12 Pseudomonas aeruginosa isolated in Europe. Journal of Antimicrobial Chemotherapy 26, 319-28.
10. Visca, P., Chiarini, F., Vetriani, C., Mansi, A., Serino, L. & Orsi, N. (1991). Epidemiological typing of uropathogenic Pseudomonas aeruginosa strains from hospitalized patients. Journal of Hospital Infection 19, 153-65.